|
|
Article: GE begins first-in-man study of PET molecular imaging agent.
- Article from:
- Medical Device Daily
- Article date:
- June 9, 2006
CopyrightCOPYRIGHT 2006 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
GE begins first-in-man study of PET molecular imaging agent
By KAREN YOUNG
Medical Device Daily Staff Writer
GE Healthcare (Chalfont St. Giles, UK) reported earlier this week that it has initiated a ?first-in-man? clinical study of a new molecular imaging agent to be used with positron emission tomography (PET), the study designed to validate the agent?s ability to provide information on the extent and nature of cancer.
Specifically, GE said, the molecular imaging agent has a biological mechanism to track the process of angiogenesis, which the company said could help physicians identify the location and growth patterns of tumors ...